Key sources included the US Food & Drug Administration (FDA), European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency (PMDA) Japan, Health Canada, Medicines and Healthcare products Regulatory Agency (MHRA) UK, International Diabetes Federation (IDF), American Diabetes Association (ADA), Obesity Society (TOS), European Association for the Study of Diabetes (EASD), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), Centers for Disease Control and Prevention (CDC) National Diabetes Statistics Report, World Health Organization (WHO) Global Health Observatory, OECD Health Statistics, IQVIA National Prescription Audit, Symphony Health prescription data, and national health ministry reports from key markets
These documents are reviewed internally and displayed as they become available
Levodopa (used for Parkinson disease) effectiveness can be reduced by high-dose B6 unless combined with carbidopa
Bring a copy of your prescription in case security questions arise